Deena Beasley

By Deena Beasley and Julie Steenhuysen CHICAGO (Reuters) - Cancer doctors should consider the financial as well as the medical impact of treatment for patients as healthcare costs continue to...

By Deena Beasley CHICAGO (Reuters) - A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according...

By Deena Beasley and Julie Steenhuysen CHICAGO (Reuters) - Cancer doctors should consider the financial as well as the medical impact of treatment for patients as healthcare costs continue to...

By Deena Beasley CHICAGO (Reuters) - Doctors can scale back treatment for certain cancer patients, based on evidence that some drugs can be used less frequently, according to new information...

By Deena Beasley (Reuters) - Britain's AstraZeneca Plc, the target of a $106 billion takeover effort by Pfizer Inc, released promising data on Wednesday for a new lung cancer treatment...

By Deena Beasley (Reuters) - Vertex Pharmaceuticals Inc on Thursday said a combination of its cystic fibrosis drug Kalydeco and an experimental compound was shown to improve lung function in...

LOS ANGELES/LONDON (Reuters) - Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc...

LOS ANGELES/LONDON (Reuters) - Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc...

(Reuters) - Pfizer Inc's experimental breast cancer drug in a clinical trial nearly doubled the amount of time patients lived without their disease getting worse, but overall survival was not...

(Reuters) - Pfizer Inc's experimental breast cancer drug in a clinical trial nearly doubled the amount of time patients lived without their disease getting worse, but overall survival was not...